biology
2 stories filed under biology on Beyond Market Intelligence. The newest of them: “Anthropic’s Biology Lab: Human Oversight Drives Early Discoveries” and “Why open data, not moats, will let AI engineer better medicine”. Anthropic's biology lab is making early discoveries, but the real headline is quieter: Claude isn't running free. Vijay Pande walked away from managing $4 billion at a16z to bet smaller, and that restraint is exactly the point. Acme AI is the next-generation, AI-powered spreadsheet platform built to replace Excel and redefine how analysts, data scientists, and enterprise teams work… The list below is every biology story on Beyond Market Intelligence, newest first.
Anthropic’s Biology Lab: Human Oversight Drives Early Discoveries
Anthropic's biology lab is making early discoveries, but the real headline is quieter: Claude isn't running free. Humans remain firmly in the loop, and that restraint is exactly what makes this work worth watching. It's a thoughtful counter to the usual rush toward full autonomy. We appreciate the discipline here; it signals maturity over hype. If you're curious how AI handles oversight in other high-stakes settings, our piece on real-world computer vision deployments offers a useful parallel. For now, this measured approach feels right.
Why open data, not moats, will let AI engineer better medicine
Vijay Pande walked away from managing $4 billion at a16z to bet smaller, and that restraint is exactly the point. His new firm, VZVC, leans into AI-native investing because he sees biology shifting from discovery to engineering. Clinical trials remain brutally expensive, and he argues open, shared datasets will matter more than proprietary walls. That conviction feels right. For a deeper look at how AI handles messy real-world data, our piece on real-world computer vision deployments is worth reading.